Koyun, D. Et Al. 2023. EVALUATION OF THE EFFICACY AND SAFETY RITUXIMAB, LENALIDOMIDE,AND IBRUTINIB IN RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA. 9th International Congress on Leukemia Lymphoma Myeloma , (Antalya, Turkey), 47-48.

Koyun, D., Şahin, U., Gökmen, A., & Özcan, M., (2023). EVALUATION OF THE EFFICACY AND SAFETY RITUXIMAB, LENALIDOMIDE,AND IBRUTINIB IN RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA . 9th International Congress on Leukemia Lymphoma Myeloma (pp.47-48). Antalya, Turkey

Koyun, Derya Et Al. "EVALUATION OF THE EFFICACY AND SAFETY RITUXIMAB, LENALIDOMIDE,AND IBRUTINIB IN RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA," 9th International Congress on Leukemia Lymphoma Myeloma, Antalya, Turkey, 2023

Koyun, Derya Et Al. "EVALUATION OF THE EFFICACY AND SAFETY RITUXIMAB, LENALIDOMIDE,AND IBRUTINIB IN RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA." 9th International Congress on Leukemia Lymphoma Myeloma , Antalya, Turkey, pp.47-48, 2023

Koyun, D. Et Al. (2023) . "EVALUATION OF THE EFFICACY AND SAFETY RITUXIMAB, LENALIDOMIDE,AND IBRUTINIB IN RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA." 9th International Congress on Leukemia Lymphoma Myeloma , Antalya, Turkey, pp.47-48.

@conferencepaper{conferencepaper, author={Derya Koyun Et Al. }, title={EVALUATION OF THE EFFICACY AND SAFETY RITUXIMAB, LENALIDOMIDE,AND IBRUTINIB IN RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA}, congress name={9th International Congress on Leukemia Lymphoma Myeloma}, city={Antalya}, country={Turkey}, year={2023}, pages={47-48} }